Parkside Financial Bank & Trust’s Soleno Therapeutics SLNO Stock Holding History

Parkside Financial Bank & Trust’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30	Closed	-$1K	–	2784
2026 Q1	$1K	Buy	30 +20	+200%	+$784	﹤0.01%	2357
2025 Q4	$463	Hold	10	–	–	﹤0.01%	2583
2025 Q3	$676	Sell	10 -12	-55%	-$890	﹤0.01%	2423
2025 Q2	$1.84K	Buy	22 +12	+120%	+$898	﹤0.01%	2035
2025 Q1	$714	Buy	+10	New	+$487	﹤0.01%	2215

Parkside Financial Bank & Trust's SLNO Position: Q2 2026 in Review

Parkside Financial Bank & Trust sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 30 shares — an estimated $1K sold.

Parkside Financial Bank & Trust first reported a position in SLNO in Q1 2025 and held it in 5 quarters. The position peaked at $1.84K in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Parkside Financial Bank & Trust reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Parkside Financial Bank & Trust sold 30 Soleno Therapeutics shares in Q2 2026, an estimated $1K.
Parkside Financial Bank & Trust first reported a position in Soleno Therapeutics in Q1 2025 and held it in 5 quarters.
Parkside Financial Bank & Trust's Soleno Therapeutics position peaked at $1.84K in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.